hand, there was no correlation between the D value and T2E or aneurysmal sac shrinkage after EVAR statistically.
Conclusions: IASP was reduced by EVAR using Endurant and Excluder. Excluder significantly reduced IASP compared to Endurant.
However those D values did not concern with T2E or aneurysmal sac shrinkage after EVAR. To reduce T2E or achieve aneurysmal sac shrinkage, alternative methods should be considered, such as embolization of T2E sources during EVAR or severe postoperative blood pressure control.
Author Disclosures: Y. Kurimoto: Medtronic Japan Co., Ltd.: consulting fees (eg, advisory boards); R. Maruyama: Nothing to disclose; K. Nakanishi: Nothing to disclose; M. Nojima: Nothing to disclose; A. Yamada: Nothing to disclose.
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Evaluation of PEVAR Therapeutic Benefits in a Large Single-Center Experience Results: During the study period, 236 cases were analyzed. Among these patients, 137 patients underwent PEVAR, and 99 patients underwent SEVAR. There were no significant differences in demographics between PEVAR and SEVAR groups (Table I) . PEVAR patients had a shorter hospital length of stay, operation time, intensive care unit time, and lower frequency of total access site complications (hematoma, pseudoaneurysm, lymphocele, infection, or dissection). Moreover, PEVAR did not increase the risk of postoperative complications, readmissions, or reoperations (Table II) .
Conclusions: In a large reported PEVAR patient group, we observed that PEVAR was a safe alternative to SEVAR. Most notably, patients who underwent PEVAR had shorter operative times, reduced hospital stay, and less access site complications. IP043.
Hypogastric Preservation Using Retrograde Endovascular Bypass
Mathew Wooster, Paul Armstrong, Martin R. Back. University of South Florida, Gainesville, Fla
Objectives: Maintenance of pelvic circulation reduces risks of ischemic colitis, buttock claudication, erectile dysfunction, and spinal cord ischemia during the treatment of extensive aortoiliac aneurysmal disease. We evaluated the mid to late follow-up of patients treated using one preservation technique, the endovascular external-to internal iliac artery (EIA-IIA) bypass.
Methods: All patients undergoing retrograde EIA-IIA endovascular bypass were retrospectively reviewed from 2006 to 2016. Anatomic inclusion criteria were common iliac artery aneurysms with or without concomitant aortic aneurysm limiting distal landing zone for endovascular repair and an iliac bifurcation angle >45
. Procedures were performed using aortouniiliac (AUI) endografts extended to one EIA, cross femoral artery bypass, and retrograde placement of covered stent grafts into the contralateral IIA. For patients with prior open repair, AUI placement was not required. Surveillance included duplex ultrasound imaging 1 month and 6 months postoperatively, and annually thereafter with computed tomography CT scan (with selective contrast usage) 1 month postoperatively and annually thereafter.
Results: Seventeen patients (mean age, 70 years; 93% male) were treated over the period. Most were treated for primary disease (n ¼ 11), while the remainder underwent secondary interventions following open repair (n ¼ 4) or endovascular repair (n ¼ 2). Nine patients had bilateral common iliac aneurysms, one had bilateral IIA aneurysms, and the remainder had unilateral iliac aneurysmal degeneration with occluded or severely diseased ipsilateral hypogastric arteries. There was no preference for laterality (right iliac, n ¼ 8; left iliac, n ¼ 9). Retrograde bypasses were performed using Fluency (n ¼ 1), Viabahn (n ¼ 13), or Gore Excluder (n ¼ 3) grafts. Hypogastric embolization with AUI extension to the EIA was required in six patients. Proximal extension requiring snorkel/fenestration was present in five patients. Technical success was 100%, with a mean operative time of 168 minutes (range, 50-300 minutes), and 71 mL contrast usage (range, 30-115 mL). Mean preoperative iliac artery aneurysm size was 4.0 cm with iliac bifurcation angle 71 (range, 51 -102 ). Median length of stay was 3 days (range, 1-13 days). Over a mean follow-up of 25.7 months, there were no aortic related deaths, one EIA-IIA bypass occlusion (asymptomatic), and one reintervention (for type II endoleak). There were no additional endoleaks and no sac growth. The incidence of bowel ischemia, paralysis, and bowel/bladder dysfunction was zero in the series.
Conclusions: Retrograde endovascular EIA-IIA bypass provides a low risk, high patency option for preservation of a single hypogastric artery with resultant maintenance of pelvic circulation.
Author Disclosures: P. Armstrong: Nothing to disclose; M. R. Back: Nothing to disclose; M. Wooster: Nothing to disclose.
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Management of Abdominal Aortic Aneurysms With Atypical Renal Artery Anatomy
Mathew Wooster, Adam Tanious, Martin R. Back. University of South Florida, Gainesville, Fla
Objectives: Renal artery anomalies occur at a rate of 1% to 2%, and with a growing number of renal transplants performed annually, we are more frequently faced with particular challenges to abdominal aortic aneurysm repair. We describe here adjuncts used to manage such anatomic variants.
Methods: This is a retrospective review of a prospectively collected database of all abdominal aortic aneurysms repaired in a single academic vascular surgery practice. Patients with renal transplants, congenital single/pelvic kidneys arising from the distal abdominal aorta or iliac arteries, and horseshoe kidneys were included in the review.
Results: Over an 8-year period, 18 patients were identified (prior renal transplant, n ¼ 9; horseshoe kidney, n ¼ 3; congenital single/pelvic kidney, n ¼ 6). All prior transplant patients were treated with endovascular repair, with four requiring aortouniiliac extension to the external iliac artery contralateral to the renal transplant for aneurysm exclusion (with retrograde flow via cross femoral bypass providing renal perfusion). Additionally, three transplant patients required carotid artery access for device deployment due to severe iliofemoral occlusive disease or origin of renal transplant off of the internal iliac artery. Two horseshoe kidney patients underwent open aneurysm repair with direct reimplantation of accessory renal arteries, while one underwent standard endovascular repair with exclusion of an isthmus branch. While there was no renal dysfunction noted, the patient did have a prolonged course of abdominal pain postoperatively due to infarct of the devascularized renal segment. Of the congenital single/pelvic kidney cohort, two underwent open repair with renal reimplantation, two underwent standard endovascular repair, one was treated with aortouniiliac and cross-femoral bypass, and one was treated in a staged fashion with initial ileorenal bypass and subsequent fenestrated endovascular repair. Intravascular ultrasound imaging was used to minimize contrast use in patients with chronic renal insufficiency (creatinine >1.2 mg/dL, n ¼ 6). Over a mean follow-up of 41.7 months (range, 1-110 months), there were no aortic related deaths or reinterventions, no decline in renal function (measured by serum creatinine and glomerular filtration rate), and 100% patency of the preserved renal arteries.
Conclusions: Atypical renal anatomy provides unique challenges to abdominal aortic aneurysm repair. The use of technical adjuncts can make repair of such aneurysms safe with good long-term outcomes that do not impair renal function. 
